Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

418 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk of malignancy associated with use of dupilumab versus other treatments in atopic dermatitis patients: a national database analysis.
Garate D, Thang CJ, Chang CT, Owji S, Murphy TL, Golovko G, Da Rosa JC, Guttman-Yassky E, Wilkerson MG, Gulati N. Garate D, et al. Among authors: guttman yassky e. J Allergy Clin Immunol Pract. 2024 Nov 27:S2213-2198(24)01180-2. doi: 10.1016/j.jaip.2024.11.015. Online ahead of print. J Allergy Clin Immunol Pract. 2024. PMID: 39613098 No abstract available.
Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b Study.
Gooderham M, Guttman-Yassky E, Igawa K, Kabashima K, Esfandiari E, Rylands AJ, Williams A, Nixon A, Dent JE, Simpson E. Gooderham M, et al. Among authors: guttman yassky e. Dermatol Ther (Heidelb). 2024 Dec;14(12):3351-3366. doi: 10.1007/s13555-024-01303-z. Epub 2024 Nov 12. Dermatol Ther (Heidelb). 2024. PMID: 39532780 Free PMC article.
Systemic Therapies for Atopic Dermatitis.
Saed S, Hawkins K, Ramsey NB, Guttman-Yassky E. Saed S, et al. Among authors: guttman yassky e. J Allergy Clin Immunol Pract. 2024 Nov;12(11):3172-3174.e11. doi: 10.1016/j.jaip.2024.08.055. J Allergy Clin Immunol Pract. 2024. PMID: 39515980 No abstract available.
A phase 2a trial of brepocitinib for cicatricial alopecia.
David E, Shokrian N, Del Duca E, Meariman M, Dubin C, Hawkins K, Andrews E, Sikand S, Singer G, Oemar B, Estrada Y, Bose S, Pulsinelli J, Mahling P, Da Rosa JC, Ungar B, Peeva E, Guttman-Yassky E. David E, et al. Among authors: guttman yassky e. J Am Acad Dermatol. 2024 Oct 24:S0190-9622(24)03043-3. doi: 10.1016/j.jaad.2024.09.073. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 39461505 Free article.
Hand Eczema. Part 2: Prevention, management, and treatment.
Bissonnette R, Agner T, Taylor JS, Molin S, Guttman-Yassky E. Bissonnette R, et al. Among authors: guttman yassky e. J Am Acad Dermatol. 2024 Oct 5:S0190-9622(24)02953-0. doi: 10.1016/j.jaad.2024.09.049. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 39374810 Review.
Hand Eczema. Part 1: epidemiology, pathogenesis, diagnosis and work-up.
Bissonnette R, Agner T, Molin S, Guttman-Yassky E. Bissonnette R, et al. Among authors: guttman yassky e. J Am Acad Dermatol. 2024 Oct 5:S0190-9622(24)02952-9. doi: 10.1016/j.jaad.2024.09.048. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 39374808 Review.
The epithelial barrier theory and its associated diseases.
Sun N, Ogulur I, Mitamura Y, Yazici D, Pat Y, Bu X, Li M, Zhu X, Babayev H, Ardicli S, Ardicli O, D'Avino P, Kiykim A, Sokolowska M, van de Veen W, Weidmann L, Akdis D, Ozdemir BG, Brüggen MC, Biedermann L, Straumann A, Kreienbühl A, Guttman-Yassky E, Santos AF, Del Giacco S, Traidl-Hoffmann C, Jackson DJ, Wang DY, Lauerma A, Breiteneder H, Zhang L, O'Mahony L, Pfaar O, O'Hehir R, Eiwegger T, Fokkens WJ, Cabanillas B, Ozdemir C, Walter K, Bayik M, Nadeau KC, Torres MJ, Akdis M, Jutel M, Agache I, Akdis CA. Sun N, et al. Among authors: guttman yassky e. Allergy. 2024 Oct 7. doi: 10.1111/all.16318. Online ahead of print. Allergy. 2024. PMID: 39370939 Review.
Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis.
Mesinkovska N, King B, Zhang X, Guttman-Yassky E, Magnolo N, Sinclair R, Mizuashi M, Shapiro J, Peeva E, Banerjee A, Takiya L, Cox LA, Wajsbrot D, Kerkmann U, Law E, Wolk R, Schaefer G. Mesinkovska N, et al. Among authors: guttman yassky e. J Dermatol. 2024 Nov;51(11):1414-1424. doi: 10.1111/1346-8138.17442. Epub 2024 Sep 27. J Dermatol. 2024. PMID: 39328096 Clinical Trial.
418 results